[Federal Register Volume 74, Number 63 (Friday, April 3, 2009)]
[Notices]
[Pages 15313-15314]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7497]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: NRC will convene a meeting of the Advisory Committee on the
Medical Uses of Isotopes (ACMUI) on May 7-8, 2009. A sample of agenda
items to be discussed during the public session includes: (1) Summary
of the enforcement process and enforcement actions against medical
licensees; (2) regulatory responsibilities of the U.S. Food and Drug
Administration; (3) ACMUI subcommittee report on byproduct material
events; (4) ACMUI subcommittee report on training and experience for
yttrium-90 microspheres users; (5) National Academy of Science report
on the production of medical isotopes using highly enriched uranium and
low enriched uranium; (6) briefing on the Veterans Affairs medical
events; (7) infiltrations of therapeutic radiopharmaceuticals as
medical events; (8) National Council on Radiation Protection &
Measurements Report 160 ``Ionizing Radiation Exposure of the Population
of the United States'' and its implications for NRC programs; (9) ACMUI
subcommittee report on training and experience for American Board of
Radiology certification; (10) medical event reporting to the
International Nuclear Event Scale; and (11) potential changes to 10 CFR
Part 35. A copy of the agenda will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by e-mailing Ms. Ashley
Cockerham at the contact information below.
Purpose: Discuss issues related to 10 CFR Part 35 Medical Use of
Byproduct Material.
Date and Time for Closed Session: May 7, 2009, from 3:15 p.m. to
5:30 p.m. This session will be closed so that ACMUI can complete self-
evaluations, discuss internal Committee business, and prepare for a
meeting with the Commission.
[[Page 15314]]
Date and Time for Open Sessions: May 7, 2009, from 8 a.m. to 3:15
p.m. and May 8, 2009, from 8 a.m. to 4:30 p.m.
Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two
White Flint North Auditorium, 11545 Rockville Pike, Rockville, Maryland
20852.
Public Participation: Any member of the public who wishes to
participate in the meeting should contact Ms. Cockerham using the
information below.
Contact Information: Ashley M. Cockerham, e-mail:
[email protected], telephone: (240) 888-7129.
Conduct of the Meeting: Leon S. Malmud, M.D., will chair the
meeting. Dr. Malmud will conduct the meeting in a manner that will
facilitate the orderly conduct of business. The following procedures
apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Cockerham at the contact information listed
above. All submittals must be received by April 30, 2009, and must
pertain to the topic on the agenda for the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the Chairman.
3. The draft transcript will be available on ACMUI's Web site
(http://www.nrc.gov/reading-rm/doc-collections/acmui/tr/) on or about
June 8, 2009. A meeting summary will be available on ACMUI's Web site
(http://www.nrc.gov/reading-rm/doc-collections/acmui/meeting-summaries/
) on or about June 22, 2009.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Cockerham of their planned
attendance.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10, U.S. Code of Federal Regulations, Part 7.
Dated: March 30, 2009.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. E9-7497 Filed 4-2-09; 8:45 am]
BILLING CODE 7590-01-P